Sponsored Links
Lymphoma Information Network » Lymphoma Info » Non-Hodgkin's Lymphoma: Chemotherapy

Non-Hodgkin's Lymphoma: Chemotherapy

Note: "Hodgkin's lymphoma, "Hodgkin's disease" and "Hodgkin lymphoma" are used interchangeably on this site.

Chemotherapy is the use of drugs to kill cancer cells and shrink tumors. Chemotherapy is a well-established and widely used treatment for all cancers and most of us probably know someone who has undergone "chemo". It follows, then, that most of us also know that chemotherapy has serious side effects.

The side effects are laregly due to the fact that, because chemotherapy is applied to the whole body (a "systemic" treatment), it not only destroys cancer cells in a specific location but harms many normal, noncancerous cells as well. Chemotherapy drugs are engineered to attack cells that divide rapidly. They do a good job of attacking mestastasizing cancer cells but also damage rapidly dividing cells such as red and white blood cells, platelets, cells in the digestive lining and, as you might guess, hair follicles.

Many advances have been made (and are still underway) in chemotherapy over the years, and more and more drugs are becoming available to target specific kinds of cancer cells and to minimize side effects.

Undergoing "chemo," however, is still a difficult process for the patient. But for lymphoma patients--especially non-Hodgkin lymphoma patients--chemotherapy is often an essential treatment because the disease often spreads throughout the body.

Chemotherapy is one of many treatment options for Lymphoma. If you are looking for some assistance with treatment options, there is a free tool available to help you understand your treatment options and possible side effects. Click here to sign up for FREE.

Patients who are looking for more advanced treatment or who have lymphoma that does not respond to standard treatment may want to consider a clinical study. Click here to find clinical trials in your area.

Chemotherapy treatments for lymphomas vary widely depending on the patient and the stage of the disease. Drugs may be taken by pill, or administered via injection. A lymphoma patient may take only a single drug or undergo a regimen involving a combination of drugs. Two types of drug agents are routinly used for chemotherapy: alkylating agents and nucleosides.

Alkylating agent
A cytotoxic (toxic to cells) agent that inhibits cell division by reacting with DNA.
Nucleosides
These inhibit DNA and RNA replication and therby prevent cancer cells from growing.

These are no longer the only options as researchers continue to develop new drugs. In fact, there are countless possible treatment regimens because drugs are frequently used in combination. With so many variables it is very important to get second or even third opinions regarding the type and stage of your lymphoma and the recommended treatment.

Here we list some of the more prevalent treatments. The type of treatment depends on the patient and on the type and stage of lymphoma. Multiple treatments might also be necessary for some patients. This is by no means comprehensive and is only intended to present a broad outline.

Single drug treatments (usually for slow-developing NHL)

  • Fludarabine
  • Cladribine
  • Chlorambucil (Leukeran®)
  • Cyclophosphamide (Neosar®)
drug bottles

Combination treatments (usually for fast-developing or recurring NHL)

CHOP
cyclophosphamide (Neosar®), hydroxydaunomycin, vincristine (Oncovin®), prednisone
CVP
cyclophosphamide, vincristine and the steroid prednisone - often given with rituximab (Mabthera®)
BACOD
bleomycin, doxorubicin (Adriamycin®), cyclophosphamide (Neosar®), vincristine (Oncovin®), dexamethasone
DHAP
dexamethasone, cytarabine, cisplatin - sometimes given with rituximab (Mabthera®)
EPOCH
etoposide, prednisone, vincristine (Oncovin®), cyclophosphamide (Neosar®), fluoxymesterone (Halotestin®)
ESHAP
etoposide, methylprednisolone, cytarabine and cisplatin - sometimes given with rituximab (Mabthera®)
FAD
fludarabine, doxorubicin, and the steroid dexamethasone
FMD
fludarabine, mitoxantrone and dexamethasone
ICE
ifosfamide, carboplatin, and etoposide - often given with rituximab (Mabthera®)
MACOP-B
methotrexate, doxorubicin (Adriamycin®), cyclophosphamide, vincristine (Oncovin®), prednisone, bleomycin
PMitCEBO
prednisolone, mitoxantrone, cyclophosphamide, etoposide, bleomycin and vincristine
Pro-MACE-CytaBOM
prednisone, methotrexate (with leucovorin rescue), doxorubicin (Adriamycin®), cyclophosphamide (Neosar®), etoposide, cytarabine, bleomycin, vincristine (Oncovin®)

Side Effects of Chemotherapy

girl losing hair

Chemotherapy is tough on the body. The drugs attack the entire body and this can produce a variety of complications. Common side effects include nausea and vomiting, diarrhea, hair loss, weight loss, Depression, mouth sores, leukopenia (decreased white blood cell count; may lower resistance to infection)

Most of the above side effects are temporary and usually (though not always) not too serious. Potentially serious side effects may include neutropenia (a severe drop in white blood cells), anemia (decreased red blood cell count), peripheral neuropathy (nerve damage), liver and kidney damage, thrombocytopenia (abnormal blood clotting), allergic reaction, and tumor lysis syndrome (specific to bulky lymphomas–cells split apart and release fragments into the bloodstream).

Alternatives to Chemotherapy

Chemotherapy is not always the best option for all lymphomas, and new treatments are emerging. Follow the links below for more information.

Sponsored Links

Cancer Support Groups

SupportGroups.com builds awareness and support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Dive Deeper

General Chemotherapy Info

Catheters

Drug Information

Side Effects

Non-Hodgkin's Lymphoma Information Pages:

disclaimer

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

Featured Treatment
searching for treatment

Featured Treatment: Zevalin®

Zevalin® (Ibritumomab tiuxetan) is a form of radioimmunotherapy (a radiolabeled monoclonal antibody) for treatment of patients with relapsed or refractory, low‑grade or follicular B‑cell non‑Hodgkin's lymphoma (NHL). "Refractory" refers to a disease that does not respond to treatment.

Zevalin is the first radioummunotherapy treatment to be FDA-approved as a first-line therapy for lymphoma. Read more...

Sponsored Links
User login
Cancer Support Groups

Cancer Support Groups

support groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Poll
What is most important to you in an Online Support Group?:
Latest Blog Entries
Did You Know?
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Incidence rates for Hodgkin’s disease have declined about 60%. Better means of diagnosis has also increased the number as doctors better understand cancer of lymphocytes verses other diseases.